Insights into Indivior Pharmaceuticals Q4 Earnings

Indivior Pharmaceuticals (NASDAQ:INDV) reported its Q4 earnings results on Thursday, February 26, 2026 at 07:00 AM.

Here's what investors need to know about the announcement.

Earnings

Indivior Pharmaceuticals beat estimated earnings by 24.24%, reporting an EPS of $0.82 versus an estimate of $0.66.

Revenue was up $60.00 million from the same period last year.

Performance in Previous Earnings

Last quarter the company beat on EPS by $0.32 which was followed by a 0.82% increase in the share price the next day.

Here's a look at Indivior Pharmaceuticals's past performance:

Quarter	Q3 2025	Q2 2025	Q1 2025	Q4 2024
EPS Estimate	0.40	0.26	0.23	0.26
EPS Actual	0.72	0.51	0.41	0.32
Revenue Estimate	261.12M	244.41M	240.13M	260.43M
Revenue Actual	314.00M	302.00M	266.00M	298.00M

To track all earnings releases for Indivior Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.